Biotech Group Acquisition Corporation (BGAC)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	98.72M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	9.87M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BGAC

Biotech Group Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of directors to focus on biotechnology companies with the potential to capitalize on the growing biotechnology sector in North America and the Asia-Pacific region (...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2022
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: BGAC